Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026)
Tectonic Therapeutic's (TECX) quarterly Free Cash Flow came in at -$18.4 million in Q1 2026, down 40.63% year-on-year from -$31.1 million in Q1 2025, and down 27.49% on a QoQ basis from -$14.5 million in Q4 2025.
Tectonic Therapeutic (TECX) Free Cash Flow (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has 10 years of Free Cash Flow data on file, last reported at -$18.4 million in Q1 2026.
- On a quarterly basis, Free Cash Flow fell 40.63% year-over-year to -$18.4 million in Q1 2026; TTM through Mar 2026 was -$65.6 million, a 3.99% decrease from a year earlier, with the FY2025 full-year figure at -$60.3 million, down 1.77% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$18.4 million, down from -$14.5 million in the prior quarter.
- Over the last five years, Free Cash Flow for TECX reached as high as -$473000.0 in Q2 2023 and fell as low as -$29.1 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$16.2 million across 5 years, with a median of -$16.3 million in 2022.
- Across the five-year window, Free Cash Flow jumped 98.38% in 2023 and sank 2734.25% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$23.9 million in 2022, then surged by 51.32% to -$11.7 million in 2023, then plunged by 44.35% to -$16.8 million in 2024, then rose by 14.05% to -$14.5 million in 2025, then decreased by 27.49% to -$18.4 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$18.4 million in Q1 2026, -$14.5 million in Q4 2025, and -$18.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Tectonic Therapeutic | 595.23 Mn | 595.23 Mn | - | -18.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -18.44 Mn |
| Mar 31, 2026 | -18.44 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Dec 31, 2025 | -14.46 Mn |
| Sep 30, 2025 | -18.00 Mn |
| Sep 30, 2025 | -18.00 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Jun 30, 2025 | -14.72 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Mar 31, 2025 | -13.11 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Dec 31, 2024 | -16.82 Mn |
| Sep 30, 2024 | -19.76 Mn |
| Sep 30, 2024 | -19.76 Mn |
| Jun 30, 2024 | -13.41 Mn |
| Jun 30, 2024 | -13.41 Mn |
| Mar 31, 2024 | -9.25 Mn |
| Mar 31, 2024 | -9.25 Mn |
| Dec 31, 2023 | -11.66 Mn |
| Dec 31, 2023 | -11.66 Mn |